Previous Article | Next Article ![]()
Infection and Immunity, January 2000, p. 120-124, Vol. 68, No. 1
Division of Immunology and
Allergy1 and Division of
Pneumology,2 Department of Medicine, Centre
Hospitalier Universitaire Vaudois, Lausanne, Switzerland
Received 16 November 1998/Returned for modification 18 February
1999/Accepted 11 October 1999
Major histocompatibility complex (MHC) class II engagement by toxic
shock syndrome toxin 1 (TSST-1) transduces signals leading to
proinflammatory cytokine gene expression (tumor necrosis factor alpha
[TNF-
0019-9567/0/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Induction of Tumor Necrosis Factor Alpha and
Interleukin-8 Gene Expression in Bronchial Epithelial Cells by
Toxic Shock Syndrome Toxin 1
]) in human monocytes. To study the proinflammatory role of
MHC class II molecules expressed by bronchial epithelial cells (BEC),
primary human BEC were isolated from surgical bronchial samples,
expanded in vitro, and cultured in the presence or absence of gamma
interferon (IFN-
) for 48 h. 125I-TSST-1 binding to
BEC pretreated with IFN-
was inhibited up to 97% by anti-MHC class
II monoclonal antibody 3B12, indicating that in BEC also MHC class II
molecules were targets for the staphylococcal exotoxin. As analyzed by
a quantitative reverse transcriptase PCR, a 1-h stimulation of BEC with
TSST-1 resulted in a vigorous expression of TNF-
and interleukin-8
(IL-8) genes. TNF-
and IL-8 expression was optimal in BEC pretreated
with 50 IU of IFN-
/ml, whereas TSST-1 stimulation of BEC
pretreated with 200 IU of IFN-
/ml failed to enhance either TNF-
or IL-8 transcripts. In a time course study, peak expression of TNF-
and IL-8 mRNA was reached 6 h after TSST-1 stimulation. These
results demonstrate that bacterial superantigen TSST-1 binds to MHC
molecules on BEC and induces TNF-
and IL-8 gene expression
upon engagement of MHC class II molecules on BEC, thus
contributing to the perpetuation of bronchial mucosa inflammation via
chemokine or cytokine gene expression.
*
Corresponding author. Mailing address: Division of
Immunology and Allergy, Centre Hospitalier Universitaire Vaudois,
CH-1011 Lausanne, Switzerland. Phone: 41 21 314-0790. Fax: 41 21 314-0791. E-mail: Francois.Spertini{at}chuv.hospvd.ch.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»